Encoding data from genetic traits relevant to illness diagnosis and heritage

Patent metadata

Field	Value
Publication number	US-11664091-B2
Application number	US-201916441690-A
Country	US
Kind code	B2
Filing date	Jun 14, 2019
Priority date	Sep 14, 2016
Publication date	May 30, 2023
Grant date	May 30, 2023

Abstract

Methods and systems are disclosed for encoding and decoding data from genetic traits. In one embodiment, the invention provides a method of encoding data from genetic traits. The method comprises encoding genetic traits information, including using quantum dot wavelengths to identify distinct genetic traits, and using numbers of the quantum dots to represent probabilities associated with the traits. In an embodiment, the invention provides a genetic characteristics decoding system for decoding genetic information encoded using quantum dots in a carrier. The decoding system comprises a light source for charging the quantum dots in the carrier; a scanner for scanning the carrier to retrieve information from the charged quantum dots; and a processing system for processing the retrieved information to determine quantum dot wavelengths to identify distinct genetic traits, and to determine numbers of the quantum dots to identify probabilities associated with the genetic traits.

First claim

The invention claimed is:

1. A method of using quantum dots for encoding in a carrier genetic related disease data, the method comprising:
selecting one or more quantities of quantum dots for encoding disease information, each of said quantities of quantum dots comprising a selected number of quantum dots having a specified size and emitting light at a specified wavelength, including:
mixing the one or more quantities of quantum dots in a carrier;
using a processing system implementing a scanner for detecting the wavelengths at which the one or more quantities of the quantum dots in the carrier emit light to identify distinct diseases, including representing each of the diseases with a respective one of the sizes of the quantum dots, and
using the processing system implementing a scanner for detecting the selected numbers of the quantum dots in the one or more quantities of the quantum dots in the carrier to represent probabilities associated with the diseases,
wherein the encoding genetic information further includes identifying one or more diseases associated with a person; and
the using the wavelengths of the quantum dots to identify distinct diseases includes identifying a quantum dot size to represent each of the one or more diseases; and
wherein the detecting the selected numbers of the quantum dots to represent probabilities associated with the diseases includes:
for each of the one or more diseases associated with the person, determining a number of quantum dots of the identified quantum dot size that represent said each of the diseases, to represent one of the probabilities, said one of the probabilities being associated with the each disease; and
wherein the encoding disease information further includes using the determined numbers of the quantum dots of the identified quantum dot sizes to create a color representation of the one or more diseases associated with the person.

2. The method according to claim 1 , wherein the identifying a quantum dot size to represent each of the one or more diseases includes performing a look-up of quantum dot sizes representing the one or more diseases in a database storing quantum dot sizes for the one or more diseases.

3. The method according to claim 1 , wherein the identifying a quantum dot size to represent each of the one or more diseases includes identifying a respective one quantum dot size for each of the one or more diseases.

4. The method according to claim 1 , wherein the encoding disease information further includes storing the color representation in a health database.

5. The method according to claim 1 , wherein the mixing the quantum dots in a carrier includes mixing the determined numbers of quantum dots of the identified quantum dot sizes into the carrier to encode the one or more diseases associated with the person in the carrier.

6. The method according to claim 1 , wherein the determining a number of quantum dots of the identified quantum dot size that represents said each of the diseases, to represent one of the probabilities includes determining each of said numbers as a respective one percentage of a defined base number.

7. The method according to claim 6 , wherein the determining each of said numbers as a respective one percentage of a defined base number includes obtaining the defined base number from a database.

8. A genetic characteristics decoding system for decoding genetic related disease information encoded using one or more quantities of quantum dots in a carrier, each of said quantities of quantum dots comprising a selected number of quantum dots having a specified size and emitting light at a specified wavelength, the decoding system comprising:
a light source for charging the one or more quantities of quantum dots in the carrier;
a scanner for scanning the carrier to retrieve information from the charged one or more quantities of quantum dots; and
a processing system for processing the retrieved information from the one or more quantities of quantum dots in the carrier to determine the wavelengths of the one or more quantities of quantum dots in the carrier to identify distinct diseases, and to determine the numbers of the quantum dots in the one or more quantities of the quantum dots in the carrier to identify probabilities associated with the diseases, wherein each of the diseases is represented by a respective one quantum dot size, the processing system further processing the retrieved information to determine a plurality of distinct quantum dot wavelengths, each of the distinct quantum dot wavelengths identifying one of the distinct diseases; and
the processing system identifying, for each of the diseases, a number of quantum dots of one of the distinct quantum dot wavelengths representing one of the probabilities, said one of the probabilities being associated with the each disease.

9. The decoding system according to claim 8 , wherein the processing system performs a look-up of quantum dot wavelengths representing the distinct diseases.

10. The decoding system according to claim 8 , wherein the processing system converts the numbers of quantum dots to percentages of a defined base number.

11. A method of decoding genetic related disease information encoded by analyzing one or more quantities of quantum dots in a carrier, each of said quantities of quantum dots comprising a selected number of quantum dots having a specified size and emitting light at a specified wavelength, the method comprising:
charging the one or more quantities of quantum dots in the carrier;
scanning the carrier to retrieve information from the charged one or more quantities of quantum dots; and
processing the retrieved information from the one or more quantities of quantum dots in the carrier to determine the wavelengths of the one or more quantities of quantum dots in the carrier to identify distinct diseases, and to determine the numbers of the quantum dots in the one or more quantities of the quantum dots in the carrier to identify probabilities associated with the diseases, wherein each of the diseases is represented by a respective one quantum dot size, and
the processing the retrieved information includes determining a plurality of distinct quantum dot wavelengths, each of the distinct quantum dot wavelengths identifying one of the distinct diseases; and
wherein the processing the retrieved information further includes identifying, for each of the diseases, a number of quantum dots of one of the distinct quantum dot wavelengths representing one of the probabilities, said one of the probabilities being associated with the each disease.

12. The method according to claim 11 , wherein the processing the retrieved information further includes performing a look-up of quantum dot wavelengths representing the distinct diseases.

13. The method according to claim 11 , wherein the processing the retrieved information further includes converting the numbers of quantum dots to percentages of a defined base number.

Assignees

• IBM

Inventors

• Esseiva Effron
• Liebinger Portela Franz Friedrich
• Monge Nunez Roxana
• Zamora Duran Edgar Adolfo

Classifications

• C12Q1/6816

  characterised by the detection means (C12Q1/6804 takes precedence) · CPC title

• G16B20/20

  Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection · CPC title

• G16B50/40

  Encryption of genetic data · CPC title

• G16B20/00

  ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations · CPC title

• G16B40/00 Primary

  ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding · CPC title